20 min

29. Immune Checkpoint Blockade Therapy in Metastatic Melanoma with Nir Hacohen, PhD Advances at Mass General Cancer Center

    • Science

Learn about how Dr. Nir Hacohen’s lab works to understand mechanism underline resistance to immune check point blockade therapy in metastatic melanoma and how his lab is setting the ground work for two potential new therapies.

Learn about how Dr. Nir Hacohen’s lab works to understand mechanism underline resistance to immune check point blockade therapy in metastatic melanoma and how his lab is setting the ground work for two potential new therapies.

20 min

Top Podcasts In Science